Last updated: January 13, 2021
Sponsor: M.D. Anderson Cancer Center
Overall Status: Completed
Phase
3
Condition
Cervical Cancer
Neoplasms
Squamous Cell Carcinoma
Treatment
N/AClinical Study ID
NCT01365156
2010-0952
NCI-2011-02400
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women with clinical stage IB2-IVA cervical squamous cell carcinoma, adenosquamous, oradenocarcinoma.
- Women with FDG-PET positive or indeterminate pelvic lymph nodes or indeterminate lowcommon iliac nodes and negative paraaortic nodes.
- Women with planned treatment of primary definitive chemoradiation therapy.
- Patient information and written informed consent form signed.
- Age >/= 18 years old
- ECOG Performance Status (PS) </= 2
- Life Expectancy >/= 3 months
Exclusion
Exclusion Criteria:
- Women with stage IA or IB1 cancer.
- Women with prior radiotherapy to the pelvis or retroperitoneal surgery.
- Women with neuroendocrine histologies, or histologies other than squamous,adenosquamous or adenocarcinoma.
- Women with FDG PETpositive high common or paraaortic lymph node metastasis confirmedby biopsy.
- Women who have undergone simple or radical hysterectomy prior to radiotherapy.
- Women with planned treatment of radiotherapy only (without chemotherapy).
- Women with planned treatment of palliative radiotherapy.
- Women with metastatic disease outside of pelvis.
- Women who have completed treatment for other malignancies (except non-melanomatousskin cancer) < 5 years from their new diagnosis of cervical cancer.
- Women who are pregnant, women who are likely to be pregnant or are breastfeeding.
- Women with any serious and/or unstable pre-existing medical, psychiatric, or othercondition that could interfere with patient's safety, provision of informed consent orcompliance to study procedures.
- (French Sites Only) Women not affiliated with Social Security System in France.
- (French Sites Only) Women deprived of liberty or under guardianship.
Study Design
Total Participants: 28
Study Start date:
August 01, 2011
Estimated Completion Date:
January 24, 2020
Study Description
Connect with a study center
Vall d'Hebron Hospital
Brussels,
BelgiumSite Not Available
Lyndon B. Johnson General Hospital
Houston, Texas 77026
United StatesSite Not Available
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.